Dermata Therapeutics (DRMAW) Q3 2025 Earnings

Aug 13Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-4.5
-3.45
-2.39
-1.34

Details

Expected EPS
-2.9
Actual EPS
-1.66
Surprise EPS
1.24
Surprise Percent
+42.76%

Description

⁨Dermata Therapeutics⁩ (⁦DRMAW⁩) has reported earnings of ⁦-1.66⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts